Related Experiment Video
Updated: Feb 27, 2026
04:50
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
Published on: January 17, 2025
879
Cholangiocarcinoma: New Insights
1Department of Gastroenterology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
Asian Pacific Journal of Cancer Prevention : APJCP
|July 4, 2017
Summary
Cholangiocarcinoma, a cancer of biliary epithelial cells, is increasingly common worldwide. While diagnosis is straightforward, effective treatment remains challenging, with surgery being the primary option for early stages.
Area of Science:
- Oncology
- Gastroenterology
- Cell Biology
Background:
- Cholangiocarcinoma (CCA) is a malignant neoplasm arising from biliary epithelial cells.
- The global incidence and mortality rates of CCA are increasing.
- CCA is increasingly recognized as a stem cell-related disease with multiple identified risk factors.
Approach:
- Diagnosis of CCA is generally straightforward.
- Therapeutic strategies for CCA are complex and challenging.
- Treatment modalities include surgery for early-stage disease, endobiliary interventions, chemotherapy, and radiotherapy.
Key Points:
- Increasing global incidence and mortality of cholangiocarcinoma.
- Recognition of cholangiocarcinoma as a stem cell disease.
- Challenges in cholangiocarcinoma therapy despite simple diagnosis.
Conclusions:
- Cholangiocarcinoma presents a significant and growing global health challenge.
- Effective therapeutic strategies for cholangiocarcinoma remain difficult to implement.
- Multimodal treatment approaches are necessary for managing cholangiocarcinoma.
